FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia | |
Zhang, Jingliao; Zhang, Yingchi; Zhang, Man; Liu, Chao; Liu, Xiaoming; Yin, Jie; Wu, Peng; Chen, Xiaojuan; Yang, Wenyu; Zhang, Li | |
2018 | |
卷号 | 132期号:23页码:2520-2524 |
ISSN号 | 0006-4971 |
DOI | 10.1182/blood-2018-04-845628 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6353871 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Zhang, Jingliao,Zhang, Yingchi,Zhang, Man,et al. FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia[J],2018,132(23):2520-2524. |
APA | Zhang, Jingliao.,Zhang, Yingchi.,Zhang, Man.,Liu, Chao.,Liu, Xiaoming.,...&Zhu, Xiaofan.(2018).FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia.,132(23),2520-2524. |
MLA | Zhang, Jingliao,et al."FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia".132.23(2018):2520-2524. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论